Compositions for topical treatment of microbial infections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for simple, inexpensive, and well-tolerated methods and compositions to apply anti-microbial compounds like glycerol monolaurate (GML) effectively to skin and mucosal surfaces to treat microbial infections.
Innovation Solution
Topical compositions comprising GML or its derivatives, combined with vegetable oils, non-aqueous gels, and pharmaceutically acceptable carriers, are developed to facilitate effective delivery to skin and mucosal surfaces, with optional inclusion of cellulose derivatives and accelerants like EDTA to enhance antimicrobial properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If anti-microbial compounds like GML are applied at effective levels to skin and mucosal surfaces, then microbial infections are treated effectively, but patient compliance deteriorates due to irritation
Solution Approach 1:
The patent modifies the physical and chemical parameters of the anti-microbial compound delivery system by using liposomal encapsulation and varying concentrations (0.1% to 10% GML). This allows the active ingredient to be delivered at effective levels while the liposomal structure reduces direct irritation to skin and mucosal surfaces, thereby maintaining patient compliance
Solution Approach 2:
The patent introduces liposomes as an intermediary carrier between the anti-microbial compound GML and the skin/mucosal surfaces. The liposomal vesicles encapsulate GML and facilitate its gradual release, reducing direct contact irritation while maintaining effective antimicrobial activity, thus resolving the contradiction between effectiveness and patient comfort
2Ease of manufacture
If simple and inexpensive compositions are used, then ease of manufacture is improved, but manufacturing precision may deteriorate
Solution Approach 1:
The patent specifies precise concentration ranges (0.1% to 10% GML, with preferred ranges of 0.5% to 5%) and uses standardized liposomal formulations with defined size distributions. These controlled parameters ensure consistent active ingredient delivery while maintaining relatively simple manufacturing processes that can be scaled cost-effectively
3Reliability
If GML is used at high concentrations to treat resistant infections, then anti-microbial effectiveness is improved, but skin irritation worsens
Solution Approach 1:
The patent uses liposomes as a protective intermediary that can deliver higher concentrations of GML (up to 10%) to the infection site while the liposomal membrane buffers the direct irritant effect on skin and mucosal surfaces. This allows effective treatment of resistant infections without proportionally increasing skin irritation
Solution Approach 2:
The patent enables localized delivery of high GML concentrations directly to the infection site through topically applied liposomal formulations. The active ingredient is concentrated where needed (at the infection site) while the liposomal carrier distributes it in a controlled manner that minimizes widespread irritation, achieving local effectiveness without global harm
Data Source
AI summary
The present invention provides compositions and methods for topical treatment of infections. The compositions comprise glycerol monolaurate or a derivative thereof, and are administered topically, for example, to treat viral, fungal or bacterial infections.